2022 annual financial data
Silence Therapeutics 2022 Net margin
Direct answer
Net margin was -232.44%.
Operating income was -49,759,502 GBP and net income was -41,032,025 GBP.
Operating cash flow was -57,044,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,653,047 GBP
- Operating income
- -49,759,502 GBP
- Net income
- -41,032,025 GBP
- Operating cash flow
- -57,044,000 GBP
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Silence Therapeutics financial years